PR93365

TEL AVIV, Israel, Dec. 1, 2021 /PRNewswire=KYODO JBN/ --

Zsquare is proud to announce that it has been named a CES(RM) 2022 Innovation

Awards Honoree for its high-performance, single-use endoscopic platform. The

2022 CES Innovation Awards program received a record high number of over 1800

submissions. The announcement was made ahead of CES 2022, the world's most

influential technology event, which will take place January 5-8 in Las Vegas

and online.

The CES Innovation Awards program, owned and produced by the Consumer

Technology Association (CTA)(RM) [https://www.cta.tech/], is an annual

competition honoring outstanding design and engineering in 27 consumer

technology product categories. The panel of Innovation Award judges

[https://ces.tech/Innovation-Awards/Meet-the-CES-2021-Judges.aspx] includes

members of the media, designers and engineers, reviews submissions based on

innovation, engineering and functionality, aesthetics and design.

Zsquare's ultra-thin, flexible, high-resolution single-use endoscopic platform

is designed to address multiple indications as well as solve unmet medical

imaging needs for other indications. The platform is designed to improve

usability, enhance diagnostic quality, eliminate risk of cross-infection and

dramatically reduce healthcare costs.

According to Asaf Shahmoon, CEO and co-founder of Zsquare, "This recognition by

CES highlights the major technological advances we achieved this year. Our

disruptive breakthroughs in the world of miniaturizing visual fiber-optics are

changing the entire cost structure of these vital medical devices, delivering

unprecedented image quality and offering flexibility to adopt single-use

endoscopic platforms in ways we never dreamed of before."

Zsquare is the only single-use endoscopic platform to deliver high-resolution

images using a flexible scope with an imaging diameter of less than 0.5mm.

Overcoming the inherent diameter versus image quality tradeoff of conventional

chip-on-the-tip designs, Zsquare's elegant solution houses the less costly

optics in a single-use shell and the high-value imaging electronics in a

detachable, reusable imaging core. The result is a solution that dramatically

reduces the optical component's diameter without compromising on image

resolution, eliminate the risk of cross-contamination, and accesses anatomies

that could never be properly imaged before.

About Zsquare: Zsquare, a privately held medical device company with

headquarters in Israel, develops single-use, high-performance endoscopes that

can expand access for a wide variety of indication, improve performance and

solve the industry's most significant unmet need to eliminate the risk of

cross-contamination.

Logo - https://mma.prnewswire.com/media/1699013/Zsquare_Logo.jpg

Contact:

Chen Goldstein

+972524258183

chen.goldstein@zsquaremedical.com

Source: Zsquare